Prot #NU UM16U03: A Randomized Phase II Study of Androgen Deprivation Therapy with or without Palbociclib in RB-Positive Metastatic Hormone-Sensitive Prostate Cancer.

  • Carneiro Filho, Benedito A (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date5/16/1612/31/17

Funding

  • University of Michigan (Prot #NU UM16U03 // Prot #NU UM16U03)
  • Pfizer Inc. (Prot #NU UM16U03 // Prot #NU UM16U03)